global prescription medicines to soar

4
Global prescription medicines to soar According to a report by the QuintilesIMS Institute for Healthcare Informatics, glob- al spending for Prescription medicines could increase to $1.5 trillion by 2021, an increase of 33%. Historically large numbers of new medicines will emerge from the R&D pipeline in the next five years, the report says we can expect a lower annual rate of growth of 4-7 percent instead of the recent 9 percent because of pricing and market access pressures, lower volume growth in pharmerging markets and greater savings from patent expires. To read more https://www.pharmacist.com/article/global-prescription-drug-spend-seen-15-trillion-2021-report Special points of interest: This bulletin is free to Inter- ested people in Pharma & Healthcare Please send names of new subscribers to Jack- [email protected] If you have articles, com- ments or story ideas, please send them to the email above www.wavedata.co.uk Lilly predicts high numbers for 2017 Financial predictions for next year show an increase of 5% average annual reve- nue for Lilly. They are also confident that they will launch at least 20 new products in 10 years, 2014 – 2023. Lilly believe that the outlook that the company is providing today should be well received and should allow for investor interest to return to what we see as an in- dustry-leading longer-term growth story To read more https://www.wessexlifescience.co.uk/news/entry/riding-high-on-new-launches-lilly-delivers-solid-guidance-for-2017-and-beyond December 2016 COMMERCIAL BULLETIN Monthly service Inside this issue Global prescription medi- cines to soar Lilly predicts high numbers for 2017 Forthcoming events Price Watch ……….UK - More concessions high- light need for change Dispensing Fee Rises October 2016 WaveData — Top ten searched products where the focus was to November 2016

Upload: others

Post on 07-Dec-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

Global prescription medicines to soar

According to a report by the QuintilesIMS Institute for Healthcare Informatics, glob-al spending for Prescription medicines could increase to $1.5 trillion by 2021, an increase of 33%. Historically large numbers of new medicines will emerge from the R&D pipeline in the next five years, the report says we can expect a lower annual rate of growth of 4-7 percent instead of the recent 9 percent because of pricing and market access pressures, lower volume growth in pharmerging markets and greater savings from patent expires.

To read more

https://www.pharmacist.com/article/global-prescription-drug-spend-seen-15-trillion-2021-report

Special points of interest:

This bulletin is free to Inter-ested people in Pharma &

Healthcare

Please send names of new subscribers to [email protected]

If you have articles, com-ments or story ideas,

please send them to the email above

www.wavedata.co.uk

Lilly predicts high numbers for 2017

Financial predictions for next year show an increase of 5% average annual reve-nue for Lilly.

They are also confident that they will launch at least 20 new products in 10 years, 2014 – 2023.

Lilly believe that the outlook that the company is providing today should be well received and should allow for investor interest to return to what we see as an in-dustry-leading longer-term growth story

To read more

https://www.wessexlifescience.co.uk/news/entry/riding-high-on-new-launches-lilly-delivers-solid-guidance-for-2017-and-beyond

December 2016

COMMERCIAL BULLETIN Monthly service

Inside this issue

Global prescription medi-cines to soar

Lilly predicts high numbers for 2017

Forthcoming events

Price Watch ……….UK - More concessions high-

light need for change

Dispensing Fee Rises October 2016

WaveData — Top ten searched products where

the focus was to

November 2016

Forthcoming events

Price Watch ……….UK

More concessions highlight need for change

Price concessions granted by the UK Department of Health (DoH) in November included as many as 18 different ingredients in 29 separate presentations. The rising tide of monthly concessions granted by the Department is just one symptom of the need to overhaul the pharmacy reimbursement system, which has been under scrutiny now for years (Generics bulletin, 3 October 2014, page 9).

To see more go to http://www.wavedata.co.uk/newinfo.asp and view our article from this month’s Generics Bulletin.

WaveData

Subscribe to the industry's comprehensive source of news and analysis.

www.generics-bulletin.com

Page 2

Organizer Date Venue Link or Email

Arthritis Research UK Clinical Study Groups - Improving clinical research in rare musculoskel-etal diseases: challenges and opportunities

3rd Feb 2017 London lisa.tait (a/t) ncl.ac.uk

Findacure Scientific Conference on Drug Re-purposing for Rare Diseases

27th Feb 17 London http://www.findacure.org.uk/scientific-conference-2017/

2nd OTCToolbox/PLG OTC Conference and Networking Event

2nd - 3rd Mar 17

London http://plg-group.com/events/2nd-otctoolbox-plg-otc-conference-and-networking-event/?doing_wp_cron=1481628502.7155408859252929687500

EMA's SME info day on the new clinical trial regulation

20th Mar 17 London http://www.delegant.co.uk/emig

PLG events

PLG AGM & 10th

Annual Awards Even-

ing 9th Feb 2017 London

www.plg-uk.com 2nd OTC Toolbox/PLG OTC Conference & Networking Event

2nd & 3rd Mar 17

London www.plg-uk.com

CPHI event dates

CPhI Istanbul 8-10 March 2017

Istanbul, Turkey cphi.com/istanbul

CPhI Japan 19-21 April 2017

Tokyo, Japan cphi.com/japan

CPhI North America 16-18 May 2017

Philadelphia, USA cphi.com/north-america

Commercial bulletin Page 3

Dispensing Fee Rises October 2016 Some GP practices mostly in rural areas provide dispensing services to patients. There are strict rules about who can or can’t be dispensed to by the GP practice; for example the patient must live more than a mile from the nearest pharmacy. The location must be rural in character and the patient must have applied to go on the dis-pensing list. There are approximately 1700 Dispensing doctor sites in the UK. Dispensing doctors receive a fee for each item that they dispense which is calculated by dividing dispensing doctors’ remuneration’ by the number of items expected to be dispensed in the relevant year. The feescale is calculated and agreed by the Technical Steering Committee, run by NHS Digital every year. Feescale changes 2016/17 NHS Digital has released the updated feescale for GMS GPs with effect from 1 October 2016. Key changes are:

the dispensing envelope for 2016/17 has increased from £176.1m to £178.2m

the average volume increase of fees is 0.54 per cent

Full details can be found on the NHS Digital website

NEW DISPENSING FEE SCALE - Effective from 1st October 2016

Please note, the Dispensing Fee is PER ITEM. Some items will attract more than one dispensing fee(see Drug Tariff).

Please note the latest dispensing fee scale can always be found inside the latest Statement of Fees and Allowances which can be found online at www.nhsemployers.org

Remember Dispex provides support and training for dispensing GP practices – if you want to know more about dispensing doctors and how to access this valuable niche market then visit www.dispex.net or email [email protected] to arrange an appointment and FREE one hour semi-nar on dispensing doctors.

Monthly service

This bulletin now goes out to 4300 plus people.

If you would like to add or suggest any articles/comments, please let me know by the 17th January 2017, as I will be issuing the next bulletin on the

24th January 2017

If you have any colleagues who would like to receive this, please let them know about it.

You can view all copies of the Bulletin at

http://www.wavedata.co.uk/newinfo.asp

Jackie Moss

WaveData Ltd

E-mail: [email protected]

Twitter @wavedata

WaveData WaveData WaveData WaveData ———— Top ten searched products Top ten searched products Top ten searched products Top ten searched products where the focus was to November 2016where the focus was to November 2016where the focus was to November 2016where the focus was to November 2016

According to WaveData, these were the most commonly investigated products in searches of the online pricing data Wavedata

Live at http://www.wavedata.nethttp://www.wavedata.nethttp://www.wavedata.nethttp://www.wavedata.net

Both uk and pi prices were viewed for each product, giving some indication of where the focus was to November 2016

WaveData prices in the top 10 article are averages.

Product 16-Sep 16-Oct 16-Nov 16-Dec

Carbimazole Tabs 20mg 100 £174.79 £176.14 £167.40 £170.45

Hydrocor(sone Tabs 10mg 30 £65.90 £60.17 £54.63 £61.21

Omeprazole Caps 20mg 28 £0.41 £0.44 £0.40 £0.50

Carbimazole Tabs 5mg 100 £67.92 £66.15 £62.45 £64.69

Amitriptyline Tabs 25mg 28 £0.42 £0.83 £0.93 £0.98

Carbocisteine Caps 375mg 120 £10.11 £10.15 £9.44 £9.72

Acetazolamide Tabs 250mg 112 £44.01 £43.26 £42.81 £38.49

Nortriptyline Tabs 10mg 100 £40.47 £39.81 £36.83 £36.97

Nortriptyline Tabs 25mg 100 £43.39 £44.73 £40.62 £40.26

Gabapen(n Caps 300mg 100 £2.69 £2.61 £2.43 £2.62